P-PINP (procollagen type I N-terminal propeptide), a marker of bone formation, did not show a compensatory increase
[DOI] [PubMed] [Google Scholar] 27.Au H.C.T., Zheng Y.J., Le G.H., Wong S., Teopiz K.M., Kwan A.T.H., Gill H., Badulescu S., Kyle V., Rosenblat J.D., et al
Competitive athletes should understand that BPC-157 use could result in a doping violation
This comparison illustrates the gap between novel molecular mechanism discovery and validated clinical translation Dihexa represents frontier neuroscience with unresolved questions, while Cerebrolysin represents established but less mechanistically precise neurotrophic therapy
After 40 weeks, 78% to 85% of adults taking Mounjaro achieved an HbA1c below 7%, compared with 23% of adults taking a placebo
All of it is sponsored by the company, involves very small populations for a short period of time and most isnt published in peer-reviewed journals